Karam Mounzer, MD

Clinical Professor of Medicine
Philadelphia Fight Community Health Centers

Disclosure(s): Epividian: Advisor/Consultant; Gilead Sciences: Advisor/Consultant, Grant/Research Support; Janssen: Advisor/Consultant, Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; Trio Health: Advisor/Consultant; ViiV: Advisor/Consultant, Grant/Research Support

Poster(s):

• 2087 - Prescription Adherence and Persistence on Oral Pre-exposure Prophylaxis (PrEP) Among PrEP-Naive (PN) Individuals After F/TAF Approval in the United States (US)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET